REFERENCES
- Barry B. W. Lipid-protein-partitioning theory of skin penetration enhancement. J. Control. Rel. 1991; 15: 237–248, [CSA]
- Baker E. J., Hadgraft J. In vitro percutaneous absorption of arildone, a highly lipophilic drug, and the appatrent no effect of the penetration enhancer azone in excised human skin. Pharm. Res. 1995; 12: 993–997, [INFOTRIEVE], [CSA], [CROSSREF]
- Barry B. W., Bennet S. Effect of penetration enhancers on the permeation of mannitol, hydrocortisone and progesterone through human skin. J. Pharm. Pharmacol. 1987; 39: 535–546, [INFOTRIEVE], [CSA]
- Bonina F. P., Carellii V., Cols G. D., et al. Vehicle effects on in vitro skin permeation of a stratum corneum affinity for model drugs caffeine and testosterone. Int. J. Pharm. 1993; 100: 41–47, [CSA], [CROSSREF]
- Cornwell P. A., Barry B. W. Effects of penetration enhancer treatment on the statistical distribution of human skin permeabilities. Int. J. Pharm. 1995; 117: 101–112, [CSA], [CROSSREF]
- Cornwell P. A., Barry B. W. The routes of penetration of ions and 5-fluorouracil across human skin and the mechanisms of action of terpene skin penetration enhancers. Int. J. Pharm. 1993; 94: 189–194, [CSA], [CROSSREF]
- El-Kattan A. F., Asbill C. S., Michniak B. B. The effect of terpene enhancer lipophilicity on the percutaneous permeation of hydrocortisone formulated in HPMC gel systems. Int. J. Pharm. 2000; 198: 179–189, [INFOTRIEVE], [CSA], [CROSSREF]
- Gorecki D. K. J., Verbeck R. K. Trazodone hydrochloride. Analytical Profile of Drug Substances, K. Florey. Academic Press, London 1987; 16: 693–729
- Goodman, Gilman A. Drugs and the treatment of psychiatric disorders. The Pharmacological Basis of Therapeutics, 8th ed. Maxwell Macmillan International, New York 1990; 383–435
- Gao S., Singh J. In vitro percutaneous absorption enhancement of lipophilic drug tamoxifen by terpenes. J. Control. Rel. 1998; 51: 193–199, [CSA], [CROSSREF]
- Goodman M., Barry B. W. Lipid-protein-partitioning (LPP) theory of skin enhancer activity: finite dose technique. Int. J. Pharm. 1989; 57: 29–40, [CSA], [CROSSREF]
- Jain A. K., Thomas N. S., Panchagnula R. Transdermal drug delivery of imipramine hydrochloride: 1. Effect of terpenes. J. Control. Rel. 2002; 79: 93–101, [CSA], [CROSSREF]
- Kaidi Z., Singh J. Mechanism of percutaneous absorption of tamoxifen by terpenes: euginol, D-limonene and menthone. J. Control. Rel. 1998; 55: 253–260, [CSA], [CROSSREF]
- Moghimi H. R., Williams A. C., Barry B. W. A lamellar matrix model for stratum corneum intercellular lipids 11. Effects of geometry of the stratum corneum on permeation of model drugs 5-flurouracil and oestradiol. Int. J. Pharm. 1996a; 131: 117–129, [CSA], [CROSSREF]
- Moghimi H. R., William A. C., Barry B. W. A lamellar matrix model for stratum corneum intercellular lipids 111. Effects of terpene penetration enhancers on the release of 5-fluorouracil and oestradiol from the matrix. Int. J. Pharm. 1996b; 145: 37–47, [CSA], [CROSSREF]
- Moghimi H. R., Williams A. C., Barry B. W. A lamellar matrix model for stratum corneum intercellular lipids 1V. Effects of terpene penetration enhancers on the permeation of 5-fluorouracil and oestradiol through the matrix. Int. J. Pharm. 1996c; 145: 49–59, [CSA], [CROSSREF]
- Monti D., Saettone M. F. Development of a transdermal patch for delivery of propafenone, preliminary studies in vitro. S.T.P. Pharm. Sci. 1997; 7: 235–240, [CSA]
- Monti D., Chetoni P., Burgalassi S., et al. Effects of different terpene-containing essential oils on permeation of estradiol through hairless mouse skin. Int. J. Pharm. 2002; 237: 209–214, [INFOTRIEVE], [CSA], [CROSSREF]
- Martin A., Bustainant P., Chun A. H. C. State of Matter. Waverly B.I., New Delhi 1996
- Narishetty S. T. K., Panchagnula P. Transdermal delivery of zidovudine: effect of terpenes and their mechanism of action. J. Control. Rel. 2004; 95: 367–379, [CSA], [CROSSREF]
- Ogiso T., Iwaki M., Paku T. Effect of various enhancers on transdermal permeation of indomethacin and urea and relationship betweem permeation parameter and enhancement factors. J. Pharm. Sci. 1995; 84: 482–488, [INFOTRIEVE], [CSA]
- Swarbrick J., Bom J. Drug permeation through human skin: 1. Effect of storage condition of skin. J. Invest. Dermatol. 1982; 78: 63–66, [INFOTRIEVE], [CSA], [CROSSREF]
- Singh P., Roberts M. S. Skin permeability and local tissue concentration of nonsteroidal anti-inflamatory drugs after topical application. J. Pharmacol. Exp. Ther. 1994; 268: 144–151, [INFOTRIEVE], [CSA]
- Vaddi H. K., Ho P. C., Chan S. Y. Terpenes in propylene glycol as skin penetration enhancers: permeation and partition of haloperidol, fourier transform infrared spectroscopy, and differential scanning calorimetry. J. Pharm. Sci. 2002; 91: 1639–1651, [INFOTRIEVE], [CSA], [CROSSREF]
- Yamane M. A., Williams A. C., Barry B. W. Terpene penetration enhancers in propylene glycol/water co-solvent systems: effectiveness and mechanism of action. J. Pharm. Pharmacol. 1995; 47: 978–989, [INFOTRIEVE], [CSA]
- Zhao K., Singh J. Mechanism(s) of in vitro percutaneous absorption enhancement of tamoxifen by enhancers. J. Pharm. Sci. 2000; 89: 771–780, [INFOTRIEVE], [CSA], [CROSSREF]